Results 41 to 50 of about 2,000 (98)

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine

Human Vaccines & Immunotherapeutics, 2017
Human papillomavirus is considered the causative factor for cervical cancer, which accounts for approximately 5% of the global cancer burden and more than 600,000 new cases annually that are attributable to HPV infection worldwide.
Zhigang Zhang, Jun Zhang, Ningshao Xia, Qinjian Zhao   +3 more
doaj   +1 more source

From Awareness to Action Study: Improving Human Papillomavirus Knowledge, Screening and Vaccine Uptake Among Mother‐Adolescent Pairs in the HOMINY Study in Nigeria: A Longitudinal Study

Journal of the International AIDS Society, Volume 29, Issue S2, July 2026.
ABSTRACT Introduction Persistent cervical infection with high‐risk human papillomavirus (HPV) in women is a leading cause of cervical cancer, and its co‐infection among people living with HIV increases the risk of other HPV‐associated cancers, including oropharyngeal and anogenital cancers.
Oluwaseun Peter, Elohor Oborevwori, Esosa Osagie, Paul Akhigbe, Nosakhare L. Idemudia, Ozoemene Obuekwe, Fidelis E. Eki‐Udoko, Nicholas Schlecht, Yana Bromberg, Praise O. Okoh‐Aihe, Nosayaba Osazuwa‐Peters, Modupe O. Coker, HOMINY Study Group   +12 more
wiley   +1 more source

MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION

Безопасность и риск фармакотерапии, 2018
Human papillomavirus refers to DNA-containing viruses and infects the skin and mucosal epithelium. One common way is to change the  expression of cellular genes by integrating the viral genome into  cellular DNA.
O. S. Alyautdina, M. A. Darmostukova
doaj   +1 more source

Human Papillomavirus: Update in Bridging Basic Science to Clinical and Public Health Innovations

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Human papillomavirus (HPV), a non‐enveloped, double‐strand DNA viral pathogen, is intricately linked with the onset of various cancers, including cervical cancer and head and neck cancers. The present paper delves into HPV's ancient recognition and significant milestones such as the discovery of its role in oncogenesis and the development of ...
Fatemeh Beygnejad, Narges Eslami, Kaveh Gharaei Nejad, Atefeh Zamani Kermanshahi, Hossein Bannazadeh Baghi   +4 more
wiley   +1 more source

Human papillomavirus: Role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa

International Journal of Infectious Diseases
Cervical cancer remains a leading cause of death among women in sub-Saharan Africa, accounting for nearly a quarter of global deaths from this disease. Its high incidence is due to the high prevalence of HIV, the persistence of human papillomavirus (HPV)
Christian Tague, Ayesha Junaid, Yousra Anwar, Sarah Asad, Dhruv Gehlot, Afsheen Azhar, Zainab Abdul Hamid, Simran Parkash, Johan Armel Domga Kaptso, Germain Cebweru Murhola, Criss Koba Mjumbe   +10 more
doaj   +1 more source

Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

Allergy, Asthma & Clinical Immunology, 2018
Aluminium salts are by far the most commonly used adjuvants in vaccines. There are only two aluminium salts which are used in clinically-approved vaccines, Alhydrogel® and AdjuPhos®, while the novel aluminium adjuvant used in Gardasil® is a sulphated ...
Emma Shardlow, Matthew Mold, Christopher Exley   +2 more
doaj   +1 more source

Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain

Frontiers in Cellular and Infection Microbiology, 2021
ContextIt has been more than 10 years since the human papillomavirus (HPV) vaccination program was initiated in most advanced countries. Thus, it seems necessary to change the uterine cervical cancer screening strategy.
Javier Freire-Salinas, Rafael Benito, Ainara Azueta, Joaquina Gil, Claudia Mendoza, Montserrat Nicolás, Pilar García-Berbel, Sonia Algarate, Javier Gómez-Román   +8 more
doaj   +1 more source

Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Oncogenic viral and bacterial infections constitute a significant portion of the global cancer burden, accounting for up to 15% of cases, particularly in low‐ and middle‐income countries. Prophylactic vaccination thus appears to be the most effective tool for preventing these preventable cancers, especially those linked to human papillomavirus
Christian Tague, Johan Domga, Ayesha Junaid, Okhesomi Rejoice Eshemokhai, Josias Kamgang Silatchom, Criss Koba Mjumbe   +5 more
wiley   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.
What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Superstitions on Human Papillomavirus in Africa: A Scoping Review

Public Health Challenges, Volume 5, Issue 2, June 2026.
Africa bears a high burden of HPV‐induced diseases; this scoping review explored how superstitions and cultural beliefs fuel vaccine hesitancy. There are widespread myths and opposition from cultural/religious leaders that drive HPV vaccine hesitancy; targeted and culturally sensitive campaigns/educations are essential to improve vaccine uptake and ...
Jimoh Amzat, Kafayat Aminu, Rita Amarachi Nwebo, Precious Nnannah, Chiamaka Norah Ezeagu, Ganiyat Amzat, Kehinde Kazeem Kanmodi   +6 more
wiley   +1 more source